MedTrace Logo

Platelet-rich Plasma (PRP) Treatment for Medial Retinaculum Tear Post Medial Patellar Dislocation

NCT00743873 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2011-07-12

No results posted yet for this study

Summary

To check the influence of injected platelet-rich plasma (PRP) on the healing of medial retinaculum and the redaction in recurrent dislocation of the patella.

Conditions

  • Patella-Dislocation

Interventions

BIOLOGICAL

Plasma Rich in Growth Factors (PRGF)

US guided IM injection 3-6mg

DRUG

placebo

injection of 6 cc of saline into injured area

Sponsors & Collaborators

  • Meir Medical Center

    lead OTHER

Principal Investigators

  • Omer Mei Dan, Dr · Meir Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2009-02-28
Completion
2009-03-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00743873 on ClinicalTrials.gov